← Back to Search

Integrated Stroke Care for Stroke (C3FIT Trial)

N/A
Waitlist Available
Led By Barry Jackson
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pre-morbid mRS Rankin score of 0-1
Pre-morbid mRS Rankin score of 0-1.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 6, and 12 months post-stroke
Awards & highlights

C3FIT Trial Summary

This trial will test a new stroke care design called an Integrated Practice Unit (IPU) to see if it is associated with decreased hospital length of stay, readmissions, and stroke recurrence, as well as lower cost.

Who is the study for?
This trial is for adults who've had a stroke within the last 7 days, can speak English or Spanish, and are not going to hospice care. They must live in the study area and be able to give consent. Those with minor disabilities before their stroke (mRS Rankin score of 0-1) are eligible.Check my eligibility
What is being tested?
The C3FIT trial compares traditional stroke centers with an Integrated Stroke Practice Unit (ISPU). ISPU offers team-based care from emergency through a year post-discharge, including home visits and telehealth support by nurses and health educators.See study design
What are the potential side effects?
Since this trial focuses on service delivery rather than medication, typical drug side effects aren't expected. However, participants may experience varying levels of stress or discomfort due to different care approaches.

C3FIT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had no or minimal disability before my current illness.
Select...
I had no or minimal disability before my current illness.
Select...
I have been diagnosed with a stroke, confirmed by brain scans.
Select...
I have been diagnosed with a stroke and my brain scan shows it.
Select...
I was admitted to the hospital within a week of my stroke.

C3FIT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 6, and 12 months post-stroke
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6, and 12 months post-stroke for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Stroke Impact Scale (SIS 3.0)
Secondary outcome measures
Depression: Patient Health Questionnaire (PHQ-9)
Modified Caregiver Strain Index (mCSI)
Modified Rankin Scale
+12 more

C3FIT Trial Design

2Treatment groups
Active Control
Group I: Integrated Stroke Practice Unit (ISPU)Active Control1 Intervention
ISPU personnel will continue with care provided under the Joint Commission-certified CSC/PSC design, including a 30-day clinic visit post-discharge. This will be supplemented by a more integrated model designed to increase coordination through team-based initiatives across the continuum of care for stroke - from acute and in-hospital care through 12 months post-discharge. Care teams will follow patients in their home or rehabilitation/skilled nursing facility monthly for 12 visits to assess recovery, manage risk factors, increase understanding, and build positive behavior change for patients and caregivers. Primary outcomes will be assessed by phone at 3, 6, and 12 months; secondary outcomes will be assessed at 3, 6, and 12 months.
Group II: Comprehensive or Primary Stroke Center (CSC/PSC)Active Control1 Intervention
CSC/PSC personnel will continue with care provided under the Joint Commission-certified CSC/PSC design, including a 30-day clinic visit post-discharge, follow-up clinic visits as recommended by their outpatient provider, and other clinic visits initiated by the patient when issues arise. Primary outcomes will be assessed by phone at 3, 6, and 12 months; secondary outcomes will be assessed at 3, 6, and 12 months.

Find a Location

Who is running the clinical trial?

Patient-Centered Outcomes Research InstituteOTHER
549 Previous Clinical Trials
29,994,748 Total Patients Enrolled
6 Trials studying Stroke
169,923 Patients Enrolled for Stroke
University of Alabama at BirminghamOTHER
1,583 Previous Clinical Trials
2,278,244 Total Patients Enrolled
36 Trials studying Stroke
85,584 Patients Enrolled for Stroke
Vanderbilt University Medical CenterLead Sponsor
856 Previous Clinical Trials
670,392 Total Patients Enrolled
11 Trials studying Stroke
4,598 Patients Enrolled for Stroke

Media Library

Comprehensive or Primary Stroke Center Clinical Trial Eligibility Overview. Trial Name: NCT04000971 — N/A
Stroke Research Study Groups: Integrated Stroke Practice Unit (ISPU), Comprehensive or Primary Stroke Center (CSC/PSC)
Stroke Clinical Trial 2023: Comprehensive or Primary Stroke Center Highlights & Side Effects. Trial Name: NCT04000971 — N/A
Comprehensive or Primary Stroke Center 2023 Treatment Timeline for Medical Study. Trial Name: NCT04000971 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many venues are currently hosting the clinical trial?

"Potential participants of this trial can be found in 18 different healthcare facilities located across the United States. These include Northwestern Memorial Hospital (Chicago), University of Kansas Medical Center (Kansas City) and Covenant Health Fort Sanders Regional Medical Centre (Knoxville)."

Answered by AI

Is this research endeavor recruiting participants?

"Per information on clinicaltrials.gov, this trial is no longer recruiting; it was first posted February 25th 2020 and had its last update May 4th 2022. Nevertheless, 1123 other medical studies are currently seeking patients."

Answered by AI

Who else is applying?

What state do they live in?
California
Massachusetts
Alabama
How old are they?
18 - 65
What site did they apply to?
Hartford Hospital
Columbia University Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~164 spots leftby Sep 2024